Darras, Lucille
Ipinazar, Célia
Gravier, Eléonore
Mercadie, Aurélie
Villaret, Aurélie
Marinescu, Razvan
Maître, Martine
Géniès, Camille
Mengeaud, Valérie
Fournier, Isabelle
Josse, Gwendal https://orcid.org/0000-0003-3375-5226
Funding for this research was provided by:
Les Laboratories Pierre Fabre
Article History
Received: 24 November 2025
Accepted: 4 March 2026
First Online: 27 March 2026
Declarations
:
: Lucille Darras, Célia Ipinazar, Eléonore Gravier, Aurélie Mercadié, Aurélie Villaret, Razvan Marinescu, Martine Maître, Camille Géniès, Valérie Mengeaud, and Gwendal Josse are employees of Pierre Fabre Dermo-Cosmetics and Personal Care, France, at the time of the preparation of this manuscript and received salaries, but they do not have any financial interest in the findings described in this manuscript. Isabelle Fournier has nothing to disclose.
: The study was performed in compliance with the Declaration of Helsinki and its subsequent amendments, as well as Good Clinical Practice guidelines (CHMP/ICH/135/1995 and integrated addendum). It also conformed to Regulation (EC) No. 1223/2009 of the European Commission and the French Decree (n°2017–884) pertaining to research on cosmetic products. As registration of studies evaluating cosmetic products is not mandatory in the European Union, the study was retrospectively registered under trial number NCT06578962 (28 August 2024) for publication. Prior to enrolment, all subjects provided written informed consent.